Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up

Luuk Stapersma, Gertrude van den Brink, Jan van der Ende, Eva M Szigethy, Michael Groeneweg, Frederieke H de Bruijne, Manon H J Hillegers, Johanna C Escher, Elisabeth M W J Utens, Luuk Stapersma, Gertrude van den Brink, Jan van der Ende, Eva M Szigethy, Michael Groeneweg, Frederieke H de Bruijne, Manon H J Hillegers, Johanna C Escher, Elisabeth M W J Utens

Abstract

Youth with inflammatory bowel disease (IBD) often experience psychological difficulties, such as anxiety and depression. This randomized controlled study tested whether a 3-month disease-specific cognitive behavioral therapy (CBT) in addition to standard medical care versus standard medical care only was effective in improving these youth's psychological outcomes. As this study was aimed at prevention, we included 70 youth (10-25 years) with IBD and symptoms of subclinical anxiety and/or depression, and measured psychological outcomes at 6- and 12-month follow-up. In general, participants in both groups showed improvements in anxiety, depression, health-related quality of life, social functioning, coping, and illness perceptions, sustained until 12 months follow-up. Overall, we found no differences between those receiving additional CBT and those receiving standard medical care only. We assume that this can be explained by the perceived low burden (both somatically and psychologically) or heightened awareness of psychological difficulties and IBD. ClinicalTrials.gov NCT02265588.

Keywords: Adolescents; Anxiety; Cognitive behavioral therapy; Depression; Inflammatory bowel disease; Psychological outcomes; Young adults.

Conflict of interest statement

JCE received financial support from Merck Sharp & Dohme (research support), Janssen (advisory board), and AbbVie (advisory board). EMS received financial support from National Institutes of Health (grant), Crohn and Colitis Fund America (grant), AbbVie (consultancy), Merck (consultancy), iHOPE Network (consultancy), and royalties for book editing from APPI. For Luuk Stapersma, Gertrude van den Brink, Jan van der Ende, Michael Groeneweg, Frederieke H. de Bruijne, Manon H.J. Hillegers, Elisabeth M.W.J. Utens none were declared.

Figures

Fig. 1
Fig. 1
CONSORT study flow chart
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7462914/bin/10880_2019_9649_Figa_HTML.jpg
Tree diagram PASCET-PI

References

    1. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families; 2001.
    1. Achenbach TM, Rescorla LA. Manual for the ASEBA adult forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families; 2003.
    1. Adamiak, T., Walkiewicz-Jedrzejczak, D., Fish, D., Brown, C., Tung, J., Khan, K., … Kugathasan, S. (2013). Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflammatory Bowel Diseases, 19, 1218–1223. 10.1097/mib.0b013e318280b13e.
    1. Arnett JJ. Adolescence and emerging adulthood: A cultural approach (International Edition) 4. Prentice Hall: Pearson; 2010.
    1. Bennebroek Evertsz, F., Sprangers, M. A. G., Sitnikova, K., Stokkers, P. C. F., Ponsioen, C. Y., Bartelsman, J., … Bockting, C. L. H. (2017). Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial. Journal of Consulting and Clinical Psychology, 85, 918–925.
    1. Best WR, Becktel JM, Singleton JW, Kern F., Jr Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444.
    1. Bodden DHM, Bögels SM, Muris P. The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71) Behaviour Research and Therapy. 2009;47:418–425. doi: 10.1016/j.brat.2009.01.015.
    1. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36–49. doi: 10.1053/j.gastro.2012.10.003.
    1. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Group, C. N. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Annals of Internal Medicine. 2017;167:40–47. doi: 10.7326/M17-0046.
    1. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. Journal of Psychosomatic Research. 2006;60:631–637. doi: 10.1016/j.jpsychores.2005.10.020.
    1. Brooks AJ, Rowse G, Ryder A, Peach EJ, Corfe BM, Lobo AJ. Systematic review: Psychological morbidity in young people with inflammatory bowel disease—Risk factors and impacts. Alimentary Pharmacology & Therapeutics. 2016;44:3–15. doi: 10.1111/apt.13645.
    1. Busscher B, Spinhoven P. Cognitive coping as a mechanism of change in cognitive-behavioral therapy for fear of flying: A longitudinal study with 3-year follow-up. Journal of Clinical Psychology. 2017;73:1064–1075. doi: 10.1002/jclp.22424.
    1. Christensen SS, Frostholm L, Ornbol E, Schroder A. Changes in illness perceptions mediated the effect of cognitive behavioural therapy in severe functional somatic syndromes. Journal of Psychosomatic Research. 2015;78:363–370. doi: 10.1016/j.jpsychores.2014.12.005.
    1. De Boer AG, Wijker W, Bartelsman JF, de Haes HC. Inflammatory Bowel Disease Questionnaire: Cross-cultural adaptation and further validation. European Journal of Gastroenterology and Hepatology. 1995;7:1043–1050. doi: 10.1097/00042737-199511000-00006.
    1. De Croon, E. M., Nieuwenhuijsen, K., Hugenholtz, N. I. R., & Van Dijk, F. J. H. (2005). Drie vragenlijsten voor diagnostiek van depressie en angststoornissen. TBV–Tijdschrift voor Bedrijfs-en Verzekeringsgeneeskunde, 13, 114–119.
    1. De Raaij EJ, Schröder C, Maissan FJ, Pool JJ, Wittink H. Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Manual Therapy. 2012;17:330–335. doi: 10.1016/j.math.2012.03.001.
    1. Forgeron P, King S, Reszel J, Fournier K. Psychosocial interventions to improve social functioning of children and adolescents with chronic physical conditions: A systematic review. Children’s Health Care. 2017 doi: 10.1080/02739615.2017.1328600.
    1. Garnefski N, Legerstee J, Kraaij V, Van Den Kommer T, Teerds JAN. Cognitive coping strategies and symptoms of depression and anxiety: A comparison between adolescents and adults. Journal of Adolescence. 2002;25:603–611. doi: 10.1006/jado.2002.0507.
    1. Ginsburg G, Keeton C, Drazdowski T, Riddle M. The utility of clinicians ratings of anxiety using the pediatric anxiety rating scale (PARS) Child & Youth Care Forum. 2011;40:93–105. doi: 10.1007/s10566-010-9125-3.
    1. Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018;154:1635–1646.e1633. doi: 10.1053/j.gastro.2018.01.027.
    1. Greenley RN, Hommel KA, Nebel J, Raboin T, Li SH, Simpson P, Mackner L. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. Journal of Pediatric Psychology. 2010;35:857–869. doi: 10.1093/jpepsy/jsp120.
    1. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Practice & Research Clinical Gastroenterology. 2004;18:509–523. doi: 10.1016/j.bpg.2004.01.002.
    1. Grootenhuis MA, Maurice-Stam H, Derkx BH, Last BF. Evaluation of a psychoeducational intervention for adolescents with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology. 2009;21:340–345. doi: 10.1097/meg.0b013e328315a215.
    1. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32:50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x.
    1. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
    1. Hill, R., Lewindon, P., Muir, R., Grange, I., Connor, F., Ee, L., … Davies, P. (2010). Quality of life in children with Crohn disease. Journal of Pediatric Gastroenterology and Nutrition, 51, 35–40. 10.1097/mpg.0b013e3181c2c0ef.
    1. Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. European Journal of Gastroenterology and Hepatology. 2012;24:64–69. doi: 10.1097/MEG.0b013e32834d09f1.
    1. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology. 1991;59:12–19. doi: 10.1037/0022-006X.59.1.12.
    1. Kappelman, M. D., Crandall, W. V., Colletti, R. B., Goudie, A., Leibowitz, I. H., Duffy, L., … Margolis, P. (2011). Short pediatric Crohn’s disease activity index for quality improvement and observational research. Inflammatory Bowel Diseases, 17, 112–117.
    1. Kendall, P. C., Cummings, C. M., Villabo, M. A., Narayanan, M. K., Treadwell, K., Birmaher, B., … Albano, A. M. (2016). Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study. Journal of Consulting and Clinical Psychology, 84, 1–14.
    1. Knowles SR, Wilson JL, Connell WR, Kamm MA. Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn’s disease guided by the common sense model of illness. Inflammatory Bowel Diseases. 2011;17:2551–2557. doi: 10.1002/ibd.21650.
    1. Levy, R. L., van Tilburg, M. A., Langer, S. L., Romano, J. M., Walker, L. S., Mancl, L. A., … Whitehead, W. E. (2016). Effects of a cognitive behavioral therapy intervention trial to improve disease outcomes in children with inflammatory bowel disease. Inflammatory Bowel Diseases, 22, 2134–2148.
    1. Loftus EV, Jr, Guerin A, Yu AP, Wu EQ, Yang M, Chao J, Mulani PM. Increased risks of developing anxiety and depression in young patients with crohn’s disease. American Journal of Gastroenterology. 2011;106:1670–1677. doi: 10.1038/ajg.2011.142.
    1. Luke SG. Evaluating significance in linear mixed-effects models in R. Behavior Research Methods. 2017;49:1494–1502. doi: 10.3758/s13428-016-0809-y.
    1. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. The American Journal of Gastroenterology. 2005;100:1386–1392. doi: 10.1111/j.1572-0241.2005.41428.x.
    1. Manhart A-K, Hellmann S, Hamelmann E, Schlarb AA. The association of sleep with inflammatory bowel disease in children and adolescents. Somnologie. 2016;20:212–218. doi: 10.1007/s11818-016-0067-3.
    1. Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. International Journal of Methods in Psychiatric Research. 2010;19:223–232. doi: 10.1002/mpr.323.
    1. McCombie AM, Mulder RT, Gearry RB. How IBD patients cope with IBD: A systematic review. Journal of Crohn’s and Colitis. 2013;7:89–106. doi: 10.1016/j.crohns.2012.05.021.
    1. Mikocka-Walus A, Andrews JM, Bampton P. Cognitive behavioral therapy for IBD. Inflammatory Bowel Diseases. 2016;22:E5–E6. doi: 10.1097/MIB.0000000000000672.
    1. Mikocka-Walus A, Pittet V, Rossel JB, von Kanel R, Swiss, IBD Cohort Study Group Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clinical Gastroenterology and Hepatology. 2016;14:829–835.e821. doi: 10.1016/j.cgh.2015.12.045.
    1. Muris P, Bodden D, Hale W, Birmaher B, Mayer B. SCARED-NL. Handleiding bij de gereviseerde Nederlandse versie van de Screen for Child Anxiety Related Emotional Disorders. Amsterdam: Boom test uitgevers; 2011.
    1. Otley A, Smith C, Nicholas D, Munk M, Avolio J, Sherman PM, Griffiths AM. The IMPACT questionnaire: A valid measure of health-related quality of life in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2002;35:557–563. doi: 10.1097/00005176-200210000-00018.
    1. Pirinen T, Kolho K-L, Ashorn M, Aronen ET. Sleep and emotional and behavioral symptoms in adolescents with inflammatory bowel disease. Sleep Disorders. 2014;2014:5. doi: 10.1155/2014/379450.
    1. Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R. Preliminary studies of the reliability and validity of the Children’s Depression Rating Scale. Journal of the American Academy of Child Psychiatry. 1984;23:191–197. doi: 10.1097/00004583-198403000-00011.
    1. Revah-Levy A, Birmaher B, Gasquet I, Falissard B. The Adolescent Depression Rating Scale (ADRS): A validation study. BMC Psychiatry. 2007;7:2. doi: 10.1186/1471-244x-7-2.
    1. Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: A meta-analytic review. Clinical Psychology Review. 2012;32:251–262. doi: 10.1016/j.cpr.2012.01.005.
    1. Rochelle TL, Fidler H. The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn’s disease. Journal of Health Psychology. 2013;18:972–983. doi: 10.1177/1359105312459094.
    1. Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatrics. 2015;169:1053–1060. doi: 10.1001/jamapediatrics.2015.1982.
    1. Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2011;53:480–488. doi: 10.1097/MPG.0b013e31822f2c32.
    1. Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: Highlighting pediatric differences in IBD. Gastroenterology Clinics of North America. 2009;38:611–628. doi: 10.1016/j.gtc.2009.07.010.
    1. Scholten, L., Willemen, A. M., Last, B. F., Maurice-Stam, H., van Dijk, E. M., Ensink, E., … Grootenhuis, M. A. (2013). Efficacy of psychosocial group intervention for children with chronic illness and their parents. Pediatrics, 131, e1196–1203.
    1. Schröder A, Rehfeld E, Ørnbøl E, Sharpe M, Licht RW, Fink P. Cognitive–behavioural group treatment for a range of functional somatic syndromes: Randomised trial. British Journal of Psychiatry. 2012;200:499–507. doi: 10.1192/bjp.bp.111.098681.
    1. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. The New England Journal of Medicine. 1987;317:1625–1629. doi: 10.1056/NEJM198712243172603.
    1. Serrano D. Error of estimation and sample size in the linear mixed model. (MA) Chapel Hill: University of North Carolina; 2008.
    1. Siebelink BM, Treffers PDA. Anxiety Disorders Interview Schedule for DSM-IV-Child Version, ADIS-C Handleiding. Amsterdam: Harcourt Test Publishers; 2001.
    1. Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, Hemert AMV. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychological Medicine. 1997;27:363–370. doi: 10.1017/S0033291796004382.
    1. Stapersma, L., van den Brink, G., van der Ende, J., Szigethy, E. M., Beukers, R., Korpershoek, T. A., … Utens, E. (2018). Effectiveness of disease-specific cognitive behavioral therapy on anxiety, depression, and quality of life in youth with inflammatory bowel disease: A randomized controlled trial. Journal of Pediatric Psychology, 43, 967–980. 10.1093/jpepsy/jsy029.
    1. Statistics Netherlands . Standaarddefinitie allochtonen. The Hague: Statistics Netherlands; 2000.
    1. Statistics Netherlands. (2010). Standaard Beroepen Classificatie 2010. The Hague: Statistics Netherlands. Retrieved from .
    1. Sweeney L, Moss-Morris R, Czuber-Dochan W, Meade L, Chumbley G, Norton C. Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2018;47:715–729. doi: 10.1111/apt.14493.
    1. Szigethy, E., Bujoreanu, S. I., Youk, A. O., Weisz, J., Benhayon, D., Fairclough, D., … DeMaso, D. R. (2014). Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 726–735. 10.1016/j.jaac.2014.04.014
    1. Szigethy, E., Kenney, E., Carpenter, J., Hardy, D. M., Fairclough, D., Bousvaros, A., … DeMaso, D. R. (2007). Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1290–1298. 10.1097/chi.0b013e3180f6341fs.
    1. Szigethy, E., McLafferty, L., & Goyal, A. (2011). Inflammatory bowel disease. Pediatric Clinics of North America, 58, 903–920, x–xi. 10.1016/j.pcl.2011.06.007.
    1. Szigethy, E., Youk, A. O., Gonzalez-Heydrich, J., Bujoreanu, S. I., Weisz, J., Fairclough, D., … DeMaso, D. R. (2015). Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn’s disease. Inflammatory Bowel Diseases, 21, 1321–1328. 10.1097/mib.0000000000000358.
    1. Thompson, R. D., Craig, A., Crawford, E. A., Fairclough, D., Gonzalez-Heydrich, J., Bousvaros, A., … Szigethy, E. (2012). Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. Journal of Clinical Psychology in Medical Settings, 19, 329–337. 10.1007/s10880-012-9301-8.
    1. Timbremont B, Braet C, Roelofs J. Handleiding Children’s Depression Inventory (herziene versie) Amsterdam: Pearson Assessment and Information B.V.; 2008.
    1. Turner, D., Otley, A. R., Mack, D., Hyams, J., de Bruijne, J., Uusoue, K., … Griffiths, A. M. (2007). Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A prospective multicenter study. Gastroenterology, 133, 423–432.
    1. Utens EMWJ, van Rijen EHM, Erdman RAM, Verhulst FC. Rotterdam’s Kwaliteit van Leven Interview. Rotterdam: Department of Child and Adolescent Psychiatry and Psychology, Erasmus MC; 2000.
    1. Van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC. Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: Study protocol of a multicentre randomised controlled trial (HAPPY-IBD) BMJ Open Gastroenterology. 2016;3:e000071. doi: 10.1136/bmjgast-2015-000071.
    1. Van der Does AJW. BDI-II-NL Handleiding. De Nederlandse versie van de Beck Depression Inventory. 2. Lisse: Harcourt Test Publishers; 2002.
    1. Van der Zaag-Loonen HJ, Grootenhuis MA, Last BF, Derkx HHF. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Quality of Life Research. 2004;13:1011–1019. doi: 10.1023/B:QURE.0000025598.89003.0c.
    1. Van Tilburg, M. A., Claar, R. L., Romano, J. M., Langer, S. L., Drossman, D. A., Whitehead, W. E., … Levy, R. L. (2017). Psychological factors may play an important role in pediatric Crohn’s disease symptoms and disability. Journal of Pediatrics, 184, 94–100.e101.
    1. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin. 2006;132:132–149. doi: 10.1037/0033-2909.132.1.132.
    1. Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton Depression Rating Scale. Journal of Affective Disorders. 2013;150:384–388. doi: 10.1016/j.jad.2013.04.028.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera